Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine

Brain Research Bulletin

Volumn 76, Issue 5, 2008, Pages 480-484

  Janjoppi, Luciana ^a   Katayama, Maria Hirata ^b   Scorza, Fulvio Alexandre ^a   Folgueira, Maria Aparecida Azevedo Koike ^b   Brentani, Mitzi ^b   Pansani, Aline Priscila ^a   Cavalheiro, Esper Abrão ^a   Arida, Ricardo Mario ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Medicina   (Brazil)

Author keywords

Epilepsy; Hippocampus; Pilocarpine; Rats; VDR

Indexed keywords

MESSENGER RNA; PILOCARPINE; SODIUM CHLORIDE; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPILEPTOGENESIS; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEIZURE; TEMPORAL LOBE EPILEPSY;

ANIMALS; BEHAVIOR, ANIMAL; EPILEPSY, TEMPORAL LOBE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MUSCARINIC AGONISTS; PILOCARPINE; RATS; RATS, WISTAR; RECEPTORS, CALCITRIOL; RNA, MESSENGER;

EID: 44649195903     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.01.002     Document Type: Article

References (43)

1. Ali F.E., Al-Bustan W.A., Al-Busairi W.A., and Al-Mulla F. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann. Pharmacother. 38 (2004) 1002-1005
2. Arida R.M., Scorza F.A., Peres C.A., and Cavalheiro E.A. The course of untreated seizures in the pilocarpine model of epilepsy. Epilepy Res. 34 (1999) 99-107
3. Armelisasso C., Vaccario M.L., Pontecorvi A., and Mazza S. Tonic clonic seizures in patients with primary hypoparathyroidism: a case report. Clin. EEG Neurosci. 35 (2004) 97-99
4. Bengzon J., Kokaia Z., Elmer E., Nanobashvili A., Kokaia M., and Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. USA 94 (1997) 10432-10437
5. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., and Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21 (2001) 98-108
6. Carswell S. Vitamin D in the nervous system: actions and therapeutic potential. In: Feldman D., Glorieux F.H., and Pike J.W. (Eds). Vitamin D (1997), Academic press, San-diego 1197-1211
7. Christiansen C., Rodbro P., and Sjo O. Anticonvulsant action" of vitamin D in apileptic patients? A controlled pilot study. Br. Med. J. 2 (1974) 258-259
8. de Viragh P.A., Haglid K.G., and Celio M.R. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc. Natl. Acad. Sci. USA 86 (1989) 3887-3890
9. Drezner M.K. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 5 (2004) s41-s47
10. Eyles D.W., Smith S., Kinobe R., Hewison M., and McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29 (2005) 21-30
11. Feron F., Burne T.H.J., Brown J., Smith E., McGrath J.J., Mackay-Sim A., and Eyles D.W. Development vitamin D3 deficiency alters the adult rat brain. Brain Res. Bull. 62 (2005) 141-148
12. Fitzpatrick L.A. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 5 (2004) s3-s15
13. Garcion E., Nataf S., Berod A., Darcy F., and Brachet P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res. Mol. Brain Res. 45 (1997) 255-267
14. Garcion E., Sindji L., Montero-Menei C., Andre C., Brachet P., and Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin d3. Glia 22 (1998) 282-294
15. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metabol. 13 (2002) 100-105
16. Gupta M.M., and Grover D.N. Hypocalcemia and convulsions. Postgrad. Med. J. 53 (1977) 330-333
17. Kalueff A.V., Eremin K.O., and Tuohimaa P. Mechanisms of neuroprotective actions of vitamin d(3). Biochemistry (Mosc.) 69 (2004) 907-911
18. Kalueff A.V., Lehtimaki K., Ylinen A., Honkaniemi J., and Peltola J. Intranasal administration of human IL-6 increases the severity of chemically induced seizure in rats. Neurosci. Lett. 365 (2004) 106-110
19. Kalueff A.V., Minasyan A., and Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res. Bull. 67 (2005) 156-160
20. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., and Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci. Lett. 394 (2006) 69-73
21. Leite J.P., Bortolotto Z.A., and Cavalheiro E.A. Spontaneous recurrent seizures in rats: Na Experimental Model of Partial Epilepsy. Neurosci. Biobehav. Rev. 14 (1990) 511-517
22. Leranth C., and Ribak C.E. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: a possible key to this region's resistance to epileptic damage. Exp. Brain Res. 85 (1991) 129-136
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
24. Mattson R.H., and Gidal B.E. Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav. 5 (2004) s36-s40
25. Medina A.E., Manhaes A.C., and Schmidt S.L. Sex differences in sensitivity to seizures elicited by pentylenetetrazol in mice. Pharmacol. Biochem. Behav. 68 (2001) 591-596
26. Musiol I.M., Stumpf W.E., Bidmon H.J., Heiss C., Mayerhofer A., and Bartke A. Vitamin D nuclear binding to neurons of the septal, substriatal and amygdaloid area in the siberian hamster brain. Neuroscience 48 (1992) 841-848
27. Offermann G., Pinto V., and Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia 20 (1979) 3-15
28. Parent J.M., and Lowenstein D.H. Mossy fiber reorganization in the epileptic hippocampus. Curr. Opin. Neurol. 10 (1997) 103-109
29. Parent J.M., Yu T.W., Leibowitz R.T., Geschwind D.H., Sloviter R.S., and Lowenstein D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 17 (1997) 3727-3738
30. Parent J.M., Janumpalli S., McNamara J.O., and Lowenstein D.H. Increased dentate granule cell neurogenesis following amygdala kindling in the adult rat. Neurosci. Lett. 247 (1998) 9-12
31. Pedrera J.D., Canal M.L., Carvajal J., Postigo S., Villa L.F., Hernández E.R., and Rico H. Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur. J. Clin. Invest. 30 (2000) 895-899
32. Prufer K., Veenstra T.D., Jirikowski G.F., and Kumar R. Distribution of 1,25 dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 16 (1999) 135-145
33. Rakic P. Neurogenesis in adult primates. Prog. Brain Res. 138 (2002) 3-14
34. Riaz S., Malcangio M., Miller M., and Tomlinson D.R. A vitamin D(3) derivate (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 42 (1999) 1308-1313
35. Scharfman H.E., Sollas A.L., and Goodman J.H. Spontaneous recurrent seizures after pilocarpine induced status epilepticus activate calbindinimmunoreactive hilar cells of the rat dentate gyrus. Neuroscience 111 (2002) 71-81
36. Siegel A., Malkowitz L., Moskovits M.J., and Christakos S. Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 298 (1984) 125-129
37. Sieghart W., and Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2 (2002) 795-816
38. Stumpf W.E., and O'Brien L.P. 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 87 (1987) 393-406
39. Tetich M., Leskiewicz M., Budziszewska B., Basta-kaim A., Kutner A., and Lason W. The third multidisciplinary conference on drug research, Pila 2002. Effects of 1alpha,25-dihydroxyvitamin D3 and some putative steroid neuroprotective agents on the hydrogen peroxide-induced damage in neuroblastoma-glioma hybrid NG108-15 cells. Acta Pol. Pharm. 60 (2003) 351-355
40. Tetich M., Kutner A., Leskiewicz M., Budziszewska B., and Lason W. Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. J. Steroid Biochem. Mol. Biol. 89 (2004) 365-370
41. Tetich M., Dziedzicka-Wasylewska M., Kusmider M., Kutner A., Leskiewicz M., Jaworska-Feil L., Budziszewska B., Kubera M., Myint A.M., Basta-Kaim A., Skowroński M., and Lasoń W. Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat. Brain Res. 1039 (2005) 1-13
42. Turski W.A., Cavalheiro E.A., Shwarz M., Czuczar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study. Behav. Brain Res. 9 (1983) 315-335
43. Veenstra T.D., Prufer K., Koenigsberger C., Brimijoin S.W., Grande J.P., and Kumar R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res. 804 (1998) 193-205